Company Focus

  • Oncopeptides is a biotech company focusing on research, development and commercialization of targeted therapies for difficult-to-treat cancers. The company uses its proprietary Peptide Drug Candidate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into ca...
  • Heidelberg Pharma is an oncology specialist and the first company to develop the toxin Amanitin into cancer therapies using its proprietary ATAC technology and to advance the biological mode of action of the toxin as a novel therapeutic principle.
  • Laverock Therapeutics is a gene-silencing company with a uniquely powerful technology which harnesses the cell’s natural gene regulatory mechanisms to develop a new generation of programmable advanced therapies to tackle major diseases.
  • Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health.
  • Seqera makes complex data analysis accessible at any scale by providing the tools to drive innovation in genomics, global health, and beyond.
  • iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel produc...
  • RSSL is a cutting-edge contract research organisation, pushing the boundaries of science and innovation to help make our world safer, healthier and more sustainable
  • TrakCel is the market leading developer of integrated cell orchestration solutions and services.
  • Curve Therapeutics is a private biotechnology company pioneering a revolutionary intracellular screening platform to enable the discovery of innovative therapeutics that address complex and challenging disease targets with the potential to transform the lives of patients
  • Kling Biotherapeutics boasts a fully owned IP portfolio featuring innovative platform technologies Kling-Select and Kling-Evolve. These cutting-edge technologies enable simultaneous discovery of novel targets and identification of fully human antibodies directly from patient-derived B cells.
  • The Company’s flagship product is ColoAlert®, an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.
  • Medigene AG (FSE: MDG1) is an immuno-oncology platform company dedicated to developing differentiated T cell therapies for treatment of solid tumors.
  • Karuna Theraputics are a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. We pride ourselves on our deep expertise in neuroscience and inventive thinking around drug discovery and develop...
  • Almeda Pharmaceuticals AG is a pharmaceutical company located in Zug, Switzerland. Our mission is to be sustainable in providing value-added, high quality pharmaceutical products to patients.
  • Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care.
  • ALTURiX's stated aim is to provide high-quality medicines at appropriate prices in markets where current prescriber and patient choices are limited, and in doing so repeatedly, develop a reputation for reliability and delivery of value.
  • Maxion Therapeutics is developing novel biologic medicines for ion channels and GPCRs, which are critical cell surface proteins involved in a wide range of untreated or poorly-treated diseases, including autoimmune conditions and chronic pain.
  • Lindus Health is an anti-CRO running radically faster and more reliable trials for life science pioneers – bringing ground-breaking treatments to patients more quickly.
  • Origin designs, manufactures and supplies healthcare packaging globally, supporting its clients by increasing speed to market, taking advantage of the latest packaging and supply chain technologies and upholding the highest safety standards.
  • Founded in 2001, Reaction Biology is a global contract research organization (CRO) that provides drug discovery and development services to biopharmaceutical customers worldwide.